Episode 12

ALL Hope For The Future

Listen to this expert interview to discover characteristics and outcomes of acute lymphoblastic leukemia (ALL) in adults and children. Dr Advani guides us in the biology and genetics of the disease in these two categories of patients, dedicating a special focus to Philadelphia-like ALL and to the clinical and prognostic role of measurable residual disease (MRD). Finally, as CAR-T therapies are becoming available to adult ALL patients, challenges and promises of this approach are discussed in the concluding part of the podcast.

Interview with: Anjali Advani. Host: Shaun McCann


What did you think of this podcast? Share your opinions with us in this short feedback survey.

Provide Feedback


Would you like to receive EBAH CME credit points for listening to podcasts? Please visit the EHA Campus and check out the EHA Unplugged catalog.

https://ehacampus.ehaweb.org/


Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.


Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/

Facebook: https://e-h-a.link/facebook

LinkedIn: https://www.linkedin.com/company/eha/

Email us:  education@ehaweb.org

Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe

Next Episode All Episodes Previous Episode

About the Podcast

Show artwork for EHA Unplugged
EHA Unplugged

Listen for free

About your host

Profile picture for European Hematology Association

European Hematology Association

The European Hematology Association promotes excellence in patient care, research, and education in hematology. We serve medical professionals, researchers, and scientists with an active interest in hematology. We are proud to be the largest European-based organization connecting hematologists worldwide to support career development and research, harmonize hematology education, and advocate for hematologists and hematology